triazoles has been researched along with Diabetes Mellitus in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (25.45) | 29.6817 |
2010's | 35 (63.64) | 24.3611 |
2020's | 6 (10.91) | 2.80 |
Authors | Studies |
---|---|
Sagar, SR; Shah, BM; Trivedi, P | 1 |
Begum, R; Garcia-Ocaña, A; Li, Y; Palit, SP; Parmar, N; Patel, R; Rathwa, N | 1 |
Eeda, V; Herlea-Pana, O; Lim, HY; Matlock, HG; Rawal, KN; Wang, W | 1 |
Chigurupati, S; Hameed, S; Khan, KM; Rafique, R; Rehman, AU; Salar, U; Seraj, F; Taha, M; Venugopal, V; Wadood, A | 1 |
Bindu, B; Manikandan, A; Vijayalakshmi, S | 1 |
Chegini, Z; Didehdar, M; Khoshbayan, A; Rajaeih, S; Salehi, M; Shariati, A | 1 |
Abdollahi, A; Ahmadikia, K; Alijani, N; Barac, A; Jafari, R; Khodavaisy, S; Mehrparvar, G; Pakdel, F; Rajaeih, S; Rezaie, Y; Salehi, M; Tabari, A | 1 |
Chen, J; Giovanni, G; Liu, G; Qiao, J; Song, Y; Wu, J; Yang, H | 1 |
Aghili, SR; Ghasemi, M; Gholinejad Ghadi, N; Haghani, I; Nikkhah, M; Seifi, Z; Shokohi, T; Vahedi Larijani, L | 1 |
Cohen, D | 1 |
Fujimoto, M; He, P; Ishibashi, R; Ishikawa, T; Kawamura, H; Kobayashi, K; Okabe, E; Onishi, S; Takemoto, M; Watanabe, K; Yamaga, M; Yokote, K | 1 |
Akay, A; Dragomir, A; Erlandsson, BE | 1 |
Fathy, A; Khashab, S; Shaheen, N; Soliman, AR; Soliman, MA | 1 |
Bussey, MR; Emanuele, MA; Lomasney, LM; Tehrani, R | 1 |
Goto, C; Mizui, T; Ohta, H; Tachi, T; Teramachi, H; Toyoshima, M; Tsuchiya, T | 1 |
Gallacher, DJ; Hemmeryckx, B; Roger Lijnen, H; Rong Lu, H; Swinnen, M | 1 |
Åsberg, A; Hartmann, A; Jenssen, T; Strøm Halden, TA; Vik, K | 1 |
Razzak, M | 1 |
Aragonés, A; del Val, F; López, J; Luque, A; Sastre, J | 1 |
Hegazy, SK | 1 |
Namba, M | 1 |
Amendola, G; Casale, M; Cinque, P; Citarella, S; De Michele, E; Della Rocca, F; Filosa, A; Nobili, B; Palmieri, F; Perrotta, S; Pugliese, U; Ragozzino, A; Tartaglione, I | 1 |
Yanai, H | 2 |
Chao, TF; Chen, SJ; Chen, TJ; Chiang, CE; Huang, CM; Lin, SJ; Liu, CJ; Wang, KL; Wu, CH; Yeh, CM | 1 |
Joseph, WS; Vlahovic, TC | 1 |
Berte, G; Bosc, D; Cantrelle, FX; Charton, J; Culot, M; Dassonneville, S; Deprez, B; Deprez-Poulain, R; Dumont, J; Duplan, I; Enée, E; Gauriot, M; Hennuyer, N; Herledan, A; Hermant, P; Jahklal, J; Landry, V; Leroux, F; Liang, WG; Lippens, G; Marechal, X; Paquet, C; Piveteau, C; Sevin, E; Staels, B; Tang, WJ; Totobenazara, J; van Endert, P; Verdelet, T; Woitrain, E | 1 |
Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
Daniele, C; Equitani, F; Guitarrini, MR; Losardo, A; Maffei, L; Monti, S; Pasin, M; Poggi, M; Pugliese, P; Smacchia, MP; Sorrentino, F; Terlizzi, F; Toscano, V | 1 |
Booth, CM; Eisenhauer, EA; Goodwin, RA; Goss, PE; Jamal, R; Shepherd, LE; Tu, D | 1 |
Avazpour, A; Badie, A; Haghpanah, S; Karimi, M; Toosi, F | 1 |
Ahmad, K; Beatty, N; Jaffer, F | 1 |
De Meester, I; Lambeir, AM; Scharpé, S | 1 |
Ahn, JH; Bae, MA; Cheon, HG; Jun, MA; Kang, NS; Kang, SK; Kim, KR; Kim, KY; Kim, SG; Kim, SS; Kim, SY; Lee, DH; Lee, JO; Park, WS; Rhee, SD; Shin, MS; Sohn, SK | 1 |
Egan, JM; Kim, W | 1 |
Miuchi, M; Miyagawa, J; Nanba, M | 1 |
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S | 1 |
Bahekar, R; Bandyopadhyay, D; Darji, B; Jadav, P; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, D; Patel, H; Patel, P; Sairam, KV; Shah, SR; Shaikh, M; Siriki, Y | 1 |
Amo, K; Ito, Y; Koganei, M; Ohminami, H; Orime, K; Sasaki, H; Shirakawa, J; Tajima, K; Takeda, E; Terauchi, Y; Togashi, Y | 1 |
Koelling, TM; Nemerovski, CW; Pinelli, NR | 1 |
Collier, DS; Haire, CE; Lane, JT; Odegaard, DE; Stevens, RB; Wrenshall, LE | 1 |
Huang, J; Li, LT; Li, YJ; Liu, RH; Wang, B; Wang, P; Zhou, LF | 1 |
Gyotoku, H; Ikeda, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, T; Kohno, S; Miyazaki, T; Miyzaki, Y; Morinaga, Y; Nakamura, S; Nishino, T; Ohno, H; Takazono, T; Yaguchi, T; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
Daskiran, M; Dickson, WM; Kozma, CM; Nigam, S; Paris, A; Virdi, NS | 1 |
Andrews, KM; Boyer, DD; Corbett, JW; DeNinno, MP; DiRico, KJ; Doran, SD; Esler, W; Etienne, JB; Houseknecht, KL; Kung, DW; Millham, ML; Olson, TV; Parker, JC; Rocke, BN; van Volkenburg, M; Wright, SW | 1 |
Fujimoto, M; Ishibashi, R; Ishikawa, T; Kawamura, H; Kitamoto, T; Kobayashi, K; Okabe, E; Onishi, S; Takemoto, M; Yokote, K | 1 |
Collet, X; Galinier, M; Harmancey, R; Lamant, M; Massabuau, P; Pathak, A; Philip-Couderc, P; Roncalli, J; Rouet, P; Senard, JM; Smih, F | 1 |
Kofteridis, D; Koutsopoulos, A; Krasagakis, K; Maraki, S; Samonis, G; Sfakianakis, A; Stefanidou, M; Tosca, A | 1 |
Brandt, ME; Dionne-Odom, J; Ferguson, TD; Langston, A; Nolte, FS; Rinaldi, MG; Schniederjan, SD; Zimmer, SM | 1 |
Edwards, JE; French, SW; Fu, Y; Gebermariam, T; Husseiny, MI; Ibrahim, AS; Lin, L; Schwartz, J; Skory, CD; Spellberg, BJ | 1 |
Singer, M | 1 |
Al-Tawfiq, JA; Amr, SS | 1 |
5 review(s) available for triazoles and Diabetes Mellitus
Article | Year |
---|---|
Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: A systematic review of case reports and case series.
Topics: Amphotericin B; Antifungal Agents; Brain Diseases; Deoxycholic Acid; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Humans; Mucormycosis; Risk Factors; Triazoles | 2020 |
[Programs for continuing medical education: a session; 7. Recent trends in treatment of diabetes mellitus].
Topics: Acarbose; Biguanides; Blood Glucose Self-Monitoring; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Routes; Drug Design; Drug Therapy, Combination; Education, Medical, Continuing; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incretins; Insulin; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
DPP4 inhibitors for diabetes--what next?
Topics: Adamantane; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Hypoxia; Neoplasms; Nitriles; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2008 |
The role of incretins in glucose homeostasis and diabetes treatment.
Topics: Animals; Diabetes Mellitus; Exenatide; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Incretins; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2008 |
[Incretin related agents for treatment of diabetes mellitus].
Topics: Adamantane; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Liraglutide; Nitriles; Peptides; Pyrazines; Pyrrolidines; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2009 |
5 trial(s) available for triazoles and Diabetes Mellitus
Article | Year |
---|---|
Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant.
Topics: Adult; Anti-Obesity Agents; Blood Glucose; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Kidney Transplantation; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Gain; Weight Loss | 2013 |
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation.
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postprandial Period; Prospective Studies; Pyrazines; Risk Factors; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles | 2014 |
Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women.
Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Lumbar Vertebrae; Metformin; Middle Aged; Osteocalcin; Osteogenesis; Osteoporosis, Postmenopausal; Postmenopause; Pyrazines; Sitagliptin Phosphate; Triazoles | 2015 |
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Bone and Bones; Bone Density; Calcium; Chelation Therapy; Child; Child, Preschool; Deferasirox; Diabetes Mellitus; Diphosphonates; Female; Humans; Hypogonadism; Hypoparathyroidism; Hypothyroidism; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Osteoporosis; Puberty, Delayed; Retrospective Studies; Triazoles; Vitamin D | 2014 |
Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Diabetes Mellitus; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles | 2014 |
45 other study(ies) available for triazoles and Diabetes Mellitus
Article | Year |
---|---|
Insights into the structural requirements of triazole derivatives as promising DPP IV inhibitors: computational investigations.
Topics: Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Humans; Models, Molecular; Molecular Docking Simulation; Quantitative Structure-Activity Relationship; Triazoles | 2022 |
A novel therapeutic combination of sitagliptin and melatonin regenerates pancreatic β-cells in mouse and human islets.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Humans; Hypoglycemic Agents; Melatonin; Mice; Pyrazines; Sitagliptin Phosphate; Triazoles | 2022 |
Hydroxybenzamide derivatives protect pancreatic β cell by suppressing unfolded protein response activation.
Topics: Apoptosis; Diabetes Mellitus; Endoribonucleases; Humans; Insulin-Secreting Cells; Protein Serine-Threonine Kinases; Triazoles; Unfolded Protein Response | 2022 |
Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Topics: alpha-Amylases; alpha-Glucosidases; Diabetes Mellitus; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Targeted Therapy; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
Topics: Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hypoglycemic Agents; Insulin; Molecular Structure; Piperazines; Pyridazines; Structure-Activity Relationship; Triazoles | 2020 |
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Coinfection; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Mucormycosis; Respiratory Distress Syndrome; Triazoles; Young Adult | 2021 |
Mucormycosis in renal transplant recipients: review of 174 reported cases.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Debridement; Deoxycholic Acid; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mucormycosis; Rhizopus; Transplant Recipients; Triazoles; Young Adult | 2017 |
Topics: Adult; Amphotericin B; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Male; Maxillary Sinus; Middle Aged; Mucorales; Mucormycosis; Opportunistic Infections; Sinusitis; Tooth Extraction; Treatment Outcome; Triazoles | 2018 |
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds.
Topics: Adamantane; Diabetes Mellitus; Dipeptides; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Linagliptin; Pancreatitis; Purines; Pyrazines; Quinazolines; Sitagliptin Phosphate; Triazoles; United States | 2013 |
Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes.
Topics: Diabetes Mellitus; Female; Glucagon; Humans; Hyperglycemia; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles; Werner Syndrome | 2013 |
A novel data-mining platform leveraging social media to monitor outcomes of Januvia.
Topics: Data Mining; Diabetes Mellitus; Humans; Hypoglycemic Agents; Pyrazines; Sitagliptin Phosphate; Social Media; Treatment Outcome; Triazoles | 2013 |
Sitagliptin-induced bilateral Achilles tendinitis.
Topics: Achilles Tendon; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Middle Aged; Pyrazines; Sitagliptin Phosphate; Tendinopathy; Triazoles | 2014 |
Pharmacoeconomic analysis of DPP-4 inhibitors.
Topics: Adamantane; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Costs and Cost Analysis; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Nitriles; Piperidines; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin | 2013 |
Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice.
Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Heart; Heart Function Tests; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
Transplantation: sitagliptin-balancing cardiovascular risk, hyperglycaemia and safety.
Topics: Diabetes Mellitus; Female; Humans; Kidney Transplantation; Male; Pyrazines; Triazoles | 2014 |
Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.
Topics: Adolescent; Adult; Diabetes Mellitus; DNA; DNA Mutational Analysis; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Mutation; Potassium Channels, Inwardly Rectifying; Pyrazines; Sitagliptin Phosphate; Time Factors; Triazoles | 2014 |
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection.
Topics: Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Pyrazines; Triazoles | 2014 |
Sitagliptin and the risk of hospitalization for heart failure: a population-based study.
Topics: Diabetes Mellitus; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Morbidity; Population Surveillance; Propensity Score; Pyrazines; Retrospective Studies; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Taiwan; Triazoles | 2014 |
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice.
Topics: Animals; Caco-2 Cells; Catalytic Domain; Diabetes Mellitus; Drug Evaluation, Preclinical; Glucose Tolerance Test; Humans; Hydroxamic Acids; Insulysin; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Molecular Targeted Therapy; Random Allocation; Structure-Activity Relationship; Triazoles | 2015 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypogonadism; Hypothyroidism; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Osteoporosis; Prevalence; Pyridones; Retrospective Studies; Transfusion Reaction; Triazoles | 2016 |
Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17.
Topics: Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Disease-Free Survival; Female; Humans; Hypertension; Letrozole; Lymphatic Metastasis; Middle Aged; Nitriles; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Triazoles | 2016 |
Evaluation of Proteinuria in β-Thalassemia Major Patients With and Without Diabetes Mellitus Taking Deferasirox.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Creatinine; Cross-Sectional Studies; Deferasirox; Deferiprone; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Iron Chelating Agents; Iron Overload; Male; Proteinuria; Pyridones; Transfusion Reaction; Triazoles; Young Adult | 2017 |
Mucormycosis pulmonary abscess, containment in a patient with uncontrolled diabetes mellitus.
Topics: Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Humans; Lung Abscess; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Pneumonectomy; Radiography, Thoracic; Surgical Flaps; Tomography, X-Ray Computed; Triazoles | 2017 |
Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors.
Topics: Binding Sites; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Humans; Inhibitory Concentration 50; Models, Chemical; Molecular Structure; Piperazine; Piperazines; Pyrazines; Sitagliptin Phosphate; Structure-Activity Relationship; Triazoles | 2008 |
I read about a new drug for diabetes called Januvia. Should I be interested in it?
Topics: Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Humans; Pyrazines; Sitagliptin Phosphate; Triazoles; Weight Gain | 2009 |
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Sitagliptin in treatment of diabetes complicated by chronic hepatitis C.
Topics: Blood Glucose; Comorbidity; Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2010 |
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
Topics: Administration, Oral; Animals; Diabetes Mellitus; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2011 |
Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.
Topics: Administration, Oral; Animals; Apoptosis; Arachidonic Acid; Diabetes Mellitus; Dietary Carbohydrates; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucokinase; Glucose; Haploinsufficiency; Insulin-Secreting Cells; Linoleic Acid; Male; Mice; Pyrazines; Receptors, Glucagon; Signal Transduction; Sitagliptin Phosphate; Sucrose; Triazoles | 2011 |
Successful long-term use of sitagliptin for the treatment of new-onset diabetes mellitus after solid organ transplantation: a case report.
Topics: Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Humans; Male; Middle Aged; Organ Transplantation; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation.
Topics: Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Kidney Transplantation; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Facile synthesis of 1,2,3-triazole analogs of SGLT2 inhibitors by 'click chemistry'.
Topics: Amino Acid Motifs; Animals; Biological Transport; Chemistry, Pharmaceutical; Click Chemistry; Diabetes Mellitus; Drug Design; Drug Evaluation, Preclinical; Glucose; Humans; Models, Chemical; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Triazoles | 2012 |
A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features.
Topics: Aged, 80 and over; Animals; Aspergillosis; Aspergillus; Bronchial Diseases; Bronchoscopy; Diabetes Mellitus; Female; Humans; Hydrogen Peroxide; Immunocompromised Host; Lung; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Association between sitagliptin adherence and self-monitoring of blood glucose.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Child; Computer Simulation; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Logistic Models; Male; Medication Adherence; Metformin; Middle Aged; Odds Ratio; Predictive Value of Tests; Pyrazines; Risk Factors; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; United States; Young Adult | 2012 |
Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cells, Cultured; Diabetes Mellitus; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Insulin; Islets of Langerhans; Ligands; Microsomes, Liver; Protein Binding; Pyrimidines; Rats; Structure-Activity Relationship; Triazoles | 2012 |
Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes.
Topics: Blood Glucose; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles; Werner Syndrome | 2012 |
ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Apolipoproteins; Chlorocebus aethiops; Chondroitin ABC Lyase; COS Cells; Diabetes Mellitus; Flavanones; Glycoproteins; Humans; Isoquinolines; Lipoproteins; Mice; Molecular Sequence Data; Myocardium; Sequence Homology, Amino Acid; Triazoles; Up-Regulation | 2006 |
Invasive cutaneous infection with Geotrichum candidum: sequential treatment with amphotericin B and voriconazole.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Diabetes Mellitus; Geotrichosis; Geotrichum; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.
Topics: Adult; Antifungal Agents; Dermatomycoses; Diabetes Mellitus; Fungi; Humans; Male; Triazoles; Zygomycosis | 2007 |
New medications help those with diabetes avoid heart trouble. Drugs mimic the body's natural insulin and glucose controls, but diet and exercise are still keys to controlling the disease.
Topics: Diabetes Mellitus; Diabetic Angiopathies; Exenatide; Heart Diseases; Humans; Hypoglycemic Agents; Metformin; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2007 |
Type 2 diabetes drug boom: is newer better?
Topics: Amyloid; Diabetes Mellitus; Exenatide; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Middle Aged; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2007 |
The iron chelator deferasirox protects mice from mucormycosis through iron starvation.
Topics: Amphotericin B; Animals; Benzoates; Deferasirox; Diabetes Mellitus; Drug Therapy, Combination; Iron; Iron Chelating Agents; Liposomes; Male; Mice; Mice, Inbred BALB C; Mucorales; Mucormycosis; Survival Rate; Th1 Cells; Th2 Cells; Triazoles | 2007 |
Management of comorbid diabetes and cancer.
Topics: Ambulatory Care; Amyloid; Comorbidity; Diabetes Mellitus; Exenatide; Humans; Hypoglycemic Agents; Inpatients; Insulin; Islet Amyloid Polypeptide; Neoplasms; Peptides; Practice Guidelines as Topic; Pyrazines; Quality of Life; Risk Factors; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms | 2007 |
Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Biopsy, Needle; Brain Abscess; Central Nervous System Fungal Infections; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Pyrimidines; Triazoles; Voriconazole | 2007 |